http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#Head http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#assertion http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#provenance http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#pubinfo http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#assertion http://purl.obolibrary.org/obo/DOID_2983 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_2983 http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00887 http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#association http://www.w3.org/2000/01/rdf-schema#label Bumetanide is contraindicated in anuria. Although bumetanide tablets can be used to induce diuresis in renal insufficiency, any marked increase in blood urea nitrogen or creatinine, or the development of oliguria during therapy of patients with progressive renal disease, is an indication for discontinuation of treatment with bumetanide tablets. Bumetanide is also contraindicated in patients in hepatic coma or in states of severe electrolyte depletion until the condition is improved or corrected. Bumetanide is contraindicated in patients hypersensitive to this drug. http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#association https://w3id.org/biolink/vocab/relation https://schema.org/MedicalContraindication https://identifiers.org/drugbank:DB00887 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#provenance http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#pubinfo http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#sig http://purl.org/nanopub/x/hasSignature IZumphNKrv/d3Q91ts1dpJjhYaWw2BgaTtDe8r2ccVnhLNLrPY4YffcLBY6B8hg5Y1kC31Porq57Lo2N4qce4KxSXorHiPfZpsjhocLmraM1Rq/t4FvRqm8sTr2q6/LeJN0ldjDqFaYChZAPe+d7aR0a9MjGojbSz9iQ2YjC5ao= http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc http://purl.org/dc/terms/created 2021-08-23T19:12:45.253+02:00 http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RApuVvBVyYxwEqsEEeOEgwJlEREo4ARm20OsT26gs8RMc https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY